Abstract
Objective: To explore the clinical benefits of transurethral resection of bladder tumors (TURBT) in treating bladder cancer. Methods: 60 bladder cancer cases were divided into a control group and an observational group according to their surgical plans. The control group underwent traditional open surgery, while the observation group underwent TURBT. The general surgical observation indicators, postoperative complication rates, and prognosis were compared between the two groups. Results: The operative time, urinary catheter indwelling time, and hospitalization time of the observation group were shorter than those of the control group. Besides, the observation group also had smaller intraoperative blood loss compared to the control group. The postoperative complications and the disease recurrence rate after 1 year of follow-up of the observation group were both lower than those of the control group (P < 0.05). There was no statistically significant difference in mortality between the two groups after 1 year of follow-up (P > 0.05). Conclusion: TURBT can shorten the operative time and accelerate the recovery of bladder cancer patients. Besides, it also has a lower risk of postoperative complications and recurrence. Therefore, it should be popularized in clinical practice.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
